1. Home
  2. BSVN vs EOLS Comparison

BSVN vs EOLS Comparison

Compare BSVN & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bank7 Corp.

BSVN

Bank7 Corp.

N/A

Current Price

$54.84

Market Cap

528.5M

Sector

Finance

ML Signal

N/A

Logo Evolus Inc.

EOLS

Evolus Inc.

N/A

Current Price

$7.79

Market Cap

529.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BSVN
EOLS
Founded
2004
2012
Country
United States
United States
Employees
125
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
528.5M
529.1M
IPO Year
2018
2018

Fundamental Metrics

Financial Performance
Metric
BSVN
EOLS
Price
$54.84
$7.79
Analyst Decision
Buy
Buy
Analyst Count
3
6
Target Price
★ $60.67
$15.00
AVG Volume (30 Days)
44.1K
★ 613.8K
Earning Date
10-14-2026
11-04-2026
Dividend Yield
★ 2.20%
N/A
EPS Growth
N/A
★ 1.23
EPS
★ 2.12
N/A
Revenue
N/A
★ $297,176,000.00
Revenue This Year
$1.01
$12.44
Revenue Next Year
$39.34
$17.37
P/E Ratio
$26.08
★ N/A
Revenue Growth
N/A
★ 11.61
52 Week Low
$38.50
$3.86
52 Week High
$57.77
$9.31

Technical Indicators

Market Signals
Indicator
BSVN
EOLS
Relative Strength Index (RSI) 53.21 45.13
Support Level $53.51 $7.59
Resistance Level $55.41 $8.47
Average True Range (ATR) 1.28 0.29
MACD -0.14 -0.06
Stochastic Oscillator 27.09 29.89

Price Performance

Historical Comparison
BSVN
EOLS

About BSVN Bank7 Corp.

Bank7 Corp is a full-service commercial bank focused on providing customers with exceptional service and meeting their banking needs through a variety of commercial and retail financial services. It offers deposit banking products, including commercial deposit services, commercial checking, money market, and other deposit accounts, and retail deposit services such as certificates of deposit, money market accounts, checking accounts, negotiable order of withdrawal accounts, savings accounts, and automated teller machine access. etc. It generates revenues from interest income from financial instruments and non-interest income and service charges on deposit accounts.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: